Co Diagnostics Stock Technical Analysis
| CODX Stock | USD 2.81 0.01 0.35% |
As of the 29th of January, Co Diagnostics owns the Standard Deviation of 34.75, coefficient of variation of 2725.42, and Market Risk Adjusted Performance of 0.1884. Co Diagnostics technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.
Co Diagnostics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CODX, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CODXCo Diagnostics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Co Diagnostics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 45.0 | Buy | 2 | Odds |
Most CODX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CODX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Co Diagnostics, talking to its executives and customers, or listening to CODX conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. Projected growth potential of CODX fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Co Diagnostics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.308 | Earnings Share (29.40) | Revenue Per Share | Quarterly Revenue Growth (0.77) | Return On Assets |
Understanding Co Diagnostics requires distinguishing between market price and book value, where the latter reflects CODX's accounting equity. The concept of intrinsic value—what Co Diagnostics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Co Diagnostics' price substantially above or below its fundamental value.
It's important to distinguish between Co Diagnostics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Co Diagnostics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Co Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Co Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Co Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Co Diagnostics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Co Diagnostics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Co Diagnostics or generate 0.0% return on investment in Co Diagnostics over 90 days. Co Diagnostics is related to or competes with Aethlon Medical, EnVVeno Medical, Allurion Technologies, Beyond Air, SINTX Technologies, Dogwood Therapeutics, and Tenon Medical. Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic te... More
Co Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Co Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Co Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 14.96 | |||
| Information Ratio | 0.0345 | |||
| Maximum Drawdown | 319.85 | |||
| Value At Risk | (20.90) | |||
| Potential Upside | 13.38 |
Co Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Co Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Co Diagnostics' standard deviation. In reality, there are many statistical measures that can use Co Diagnostics historical prices to predict the future Co Diagnostics' volatility.| Risk Adjusted Performance | 0.0368 | |||
| Jensen Alpha | 0.805 | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | 0.0802 | |||
| Treynor Ratio | 0.1784 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Co Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Co Diagnostics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0368 | |||
| Market Risk Adjusted Performance | 0.1884 | |||
| Mean Deviation | 11.53 | |||
| Semi Deviation | 13.73 | |||
| Downside Deviation | 14.96 | |||
| Coefficient Of Variation | 2725.42 | |||
| Standard Deviation | 34.75 | |||
| Variance | 1207.72 | |||
| Information Ratio | 0.0345 | |||
| Jensen Alpha | 0.805 | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | 0.0802 | |||
| Treynor Ratio | 0.1784 | |||
| Maximum Drawdown | 319.85 | |||
| Value At Risk | (20.90) | |||
| Potential Upside | 13.38 | |||
| Downside Variance | 223.79 | |||
| Semi Variance | 188.49 | |||
| Expected Short fall | (17.02) | |||
| Skewness | 6.35 | |||
| Kurtosis | 48.47 |
Co Diagnostics Backtested Returns
Co Diagnostics retains Efficiency (Sharpe Ratio) of -0.15, which signifies that the company had a -0.15 % return per unit of price deviation over the last 3 months. Co Diagnostics exposes twenty-seven different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Co Diagnostics' Standard Deviation of 34.75, coefficient of variation of 2725.42, and Market Risk Adjusted Performance of 0.1884 to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 7.09, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Co Diagnostics will likely underperform. At this point, Co Diagnostics has a negative expected return of -1.76%. Please make sure to confirm Co Diagnostics' treynor ratio, and the relationship between the coefficient of variation and semi variance , to decide if Co Diagnostics performance from the past will be repeated in the future.
Auto-correlation | 0.51 |
Modest predictability
Co Diagnostics has modest predictability. Overlapping area represents the amount of predictability between Co Diagnostics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Co Diagnostics price movement. The serial correlation of 0.51 indicates that about 51.0% of current Co Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 4.07 |
Co Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Co Diagnostics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Co Diagnostics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Co Diagnostics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Co Diagnostics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Co Diagnostics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Co Diagnostics price pattern first instead of the macroeconomic environment surrounding Co Diagnostics. By analyzing Co Diagnostics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Co Diagnostics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Co Diagnostics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.82 | 0.3 | 0.27 | 0.26 | Days Of Inventory On Hand | 145.19 | 391.89 | 450.67 | 428.14 |
Co Diagnostics January 29, 2026 Technical Indicators
Most technical analysis of CODX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CODX from various momentum indicators to cycle indicators. When you analyze CODX charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0368 | |||
| Market Risk Adjusted Performance | 0.1884 | |||
| Mean Deviation | 11.53 | |||
| Semi Deviation | 13.73 | |||
| Downside Deviation | 14.96 | |||
| Coefficient Of Variation | 2725.42 | |||
| Standard Deviation | 34.75 | |||
| Variance | 1207.72 | |||
| Information Ratio | 0.0345 | |||
| Jensen Alpha | 0.805 | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | 0.0802 | |||
| Treynor Ratio | 0.1784 | |||
| Maximum Drawdown | 319.85 | |||
| Value At Risk | (20.90) | |||
| Potential Upside | 13.38 | |||
| Downside Variance | 223.79 | |||
| Semi Variance | 188.49 | |||
| Expected Short fall | (17.02) | |||
| Skewness | 6.35 | |||
| Kurtosis | 48.47 |
Co Diagnostics January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CODX stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.81 | ||
| Day Typical Price | 2.81 | ||
| Price Action Indicator | 0.00 |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.